Vertex Pharmaceuticals Inc
F:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
F:VX1
|
US |
|
W
|
Washington H Soul Pattinson and Company Ltd
SWB:WD3
|
AU |
|
Open Lending Corp
NASDAQ:LPRO
|
US |
|
Advantage Solutions Inc
NASDAQ:ADV
|
US |
|
Beeline Holdings Inc
NASDAQ:BLNE
|
US |
|
D
|
Dalipal Holdings Ltd
HKEX:1921
|
CN |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
K
|
Koninklijke Philips NV
DUS:PHI1
|
NL |
|
I
|
Intekplus Co Ltd
KOSDAQ:064290
|
KR |
|
Alpha Systems Inc
F:AN5
|
JP |
|
Credit Agricole SA
PAR:ACA
|
FR |
|
Dillard's Inc
NYSE:DDS
|
US |
|
Alexco Resource Corp
TSX:AXU
|
CA |
|
CAE Inc
TSX:CAE
|
CA |
|
Coloplast A/S
CSE:COLO B
|
DK |
Present Value Calculation
This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.
DCF Model
Base Case Scenario
Switching the operating model will discard any changes made to the current valuation.
DCF Model
DCF Value Calculation
This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.
Present Value to DCF Value
Capital Structure
DCF Capital Structure
Valuation Analysis
Sensitivity Analysis
DCF Value Sensitivity Analysis
Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.
DCF Sensitivity Analysis
DCF Financials
Financials used in DCF Calculation
DCF Financials
What is the DCF value of one VX1 stock?
Estimated DCF Value of one
VX1
stock is
hidden
EUR.
Compared to the current market price of 369.3 EUR, the stock is
hidden
.
The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.
How was the DCF Value calculated?
1. Present Value Calculation.
Utilizing the DCF operating model, Vertex Pharmaceuticals Inc's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at
hidden
.
2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of hidden per share.
